Reduction-Mediated Technetium-99m Labeling of Monoclonal Antibodies
A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with 99mTc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater tha...
Saved in:
Published in | The Journal of nuclear medicine (1978) Vol. 31; no. 5; pp. 692 - 697 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Reston, VA
Soc Nuclear Med
01.05.1990
Society of Nuclear Medicine |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with 99mTc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater than 97%), in a final labeling step taking only a few minutes, can be routinely obtained with high in-vitro stability over 24 hr. No effect upon antibody reactivity is seen. |
---|---|
AbstractList | A simple and generally applicable method for labeling antibodies with technetium-99m ({sup 99m}Tc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with {sup 99m}Tc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater than 97%), in a final labeling step taking only a few minutes, can be routinely obtained with high in-vitro stability over 24 hr. No effect upon antibody reactivity is seen. A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with 99mTc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater than 97%), in a final labeling step taking only a few minutes, can be routinely obtained with high in-vitro stability over 24 hr. No effect upon antibody reactivity is seen. |
Author | Mather, Stephen J Ellison, David |
Author_xml | – sequence: 1 fullname: Mather, Stephen J – sequence: 2 fullname: Ellison, David |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4345270$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/2341907$$D View this record in MEDLINE/PubMed https://www.osti.gov/biblio/6743757$$D View this record in Osti.gov |
BookMark | eNpFkEtLxDAUhYMo4_j4CUIRcVdokiZpljL4ghkE0XVIb26dSJtokyL-ezs46Oouzsd3DveEHIYY8IAsqeCiFFKqQ7KsqKSlEJU4JicpvVdVJZumWZAF4zXVlVqS1TO6CbKPodyg8zajK14QtgGzn4ZS66FY2xZ7H96K2BWbGCL0Mdi-uAnZt9F5TGfkqLN9wvP9PSWvd7cvq4dy_XT_uLpZl1tWNbkEpt2s0h1YAKmUgNYqYDXlDbXYcRCi7dw8CyTTitWCsUY7ymnbdc41kp-Sy19vTNmbBD7PQyGGgJCNVDVXQs3Q9S_0McbPCVM2g0-AfW8DxikZpZVSjdyBF3twagd05mP0gx2_zf41c361z20C23ejDeDTH1bzeaCq_vu2_m375Uc0YYIe7bhzvoeBUyOM1Iz_AFPOe-E |
ContentType | Journal Article |
Copyright | 1993 INIST-CNRS |
Copyright_xml | – notice: 1993 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM 7X8 OTOTI |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic OSTI.GOV |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-5667 |
EndPage | 697 |
ExternalDocumentID | 6743757 2341907 4345270 jnm31_5_692 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 08R 2WC 3O- 53G 55 5RE 8WZ A6W ABEFU ABFLS ABSGY ACGOD ACIWK ACPRK ADACO ADBIT ADDZX AENEX AFFNX AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 E3Z EBS EJD F5P FH7 GJ H13 I-F IL9 INIJC J5H KQ8 L7B OK1 P2P R0Z RHF RHI RNS SJN SV3 TSM VH1 WH7 WOQ X X7M YQJ ZA5 ZGI ZXP --- -~X .55 .GJ 29L 3V. 41~ 7RV 7X7 88E 88I 8AF 8AO 8FE 8FG 8FH 8FI 8FJ 8R4 8R5 AAUGY ABLYK ABSQV ABUWG AFKRA AFOSN AI. ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI CCPQU DWQXO EBD EMOBN EX3 F9R FYUFA GNUQQ HCIFZ I4R IQODW LK8 M1P M2P M2Q M7P N4W NAPCQ P62 PQQKQ PROAC PSQYO Q2X RWL S0X TAE TR2 TUS UKHRP W8F WOW YHG ALIPV CGR CUY CVF ECM EIF HMCUK NPM 7X8 OTOTI |
ID | FETCH-LOGICAL-h208t-c29dabe9fcacc6775cba7c241381aef3c55bfd190c62972452289d131bffdd863 |
ISSN | 0161-5505 |
IngestDate | Fri May 19 00:36:56 EDT 2023 Fri Oct 25 05:54:10 EDT 2024 Sat Sep 28 07:34:13 EDT 2024 Sun Oct 29 17:09:25 EDT 2023 Mon Jan 18 12:03:20 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Nuclear medicine Technetium Monoclonal antibody Radiolabelling Radiopharmaceuticals |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-h208t-c29dabe9fcacc6775cba7c241381aef3c55bfd190c62972452289d131bffdd863 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 None |
PMID | 2341907 |
PQID | 79777867 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | osti_scitechconnect_6743757 proquest_miscellaneous_79777867 pubmed_primary_2341907 pascalfrancis_primary_4345270 highwire_nuclearmed_jnm31_5_692 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 1900 |
PublicationDate | 1990-May |
PublicationDateYYYYMMDD | 1990-05-01 |
PublicationDate_xml | – month: 05 year: 1990 text: 1990-May |
PublicationDecade | 1990 |
PublicationPlace | Reston, VA |
PublicationPlace_xml | – name: Reston, VA – name: United States |
PublicationTitle | The Journal of nuclear medicine (1978) |
PublicationTitleAlternate | J Nucl Med |
PublicationYear | 1990 |
Publisher | Soc Nuclear Med Society of Nuclear Medicine |
Publisher_xml | – name: Soc Nuclear Med – name: Society of Nuclear Medicine |
SSID | ssj0006888 |
Score | 1.7751834 |
Snippet | A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds,... A simple and generally applicable method for labeling antibodies with technetium-99m ({sup 99m}Tc) is described. Following reduction of intrinsic disulphide... |
SourceID | osti proquest pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 692 |
SubjectTerms | 550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-) ANIMALS ANTIBODIES Antibodies, Monoclonal - pharmacokinetics BETA DECAY RADIOISOTOPES BETA-MINUS DECAY RADIOISOTOPES Biological and medical sciences DISTRIBUTION HOURS LIVING RADIOISOTOPES INTERMEDIATE MASS NUCLEI Investigative techniques, diagnostic techniques (general aspects) ISOMERIC NUCLEI ISOMERIC TRANSITION ISOTOPES Isotope Labeling - methods ISOTOPES LABELLING MAMMALS Medical sciences MICE MONOCLONAL ANTIBODIES NUCLEI ODD-EVEN NUCLEI RADIOISOTOPES RADIOLOGY AND NUCLEAR MEDICINE RODENTS STABILITY Technetium TECHNETIUM 99 TECHNETIUM ISOTOPES TISSUE DISTRIBUTION VERTEBRATES YEARS LIVING RADIOISOTOPES 550601 -- Medicine-- Unsealed Radionuclides in Diagnostics |
Title | Reduction-Mediated Technetium-99m Labeling of Monoclonal Antibodies |
URI | http://jnm.snmjournals.org/cgi/content/abstract/31/5/692 https://www.ncbi.nlm.nih.gov/pubmed/2341907 https://search.proquest.com/docview/79777867 https://www.osti.gov/biblio/6743757 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT-MwFLYAaRAXBMMgyjY5cEMeZbOdHBGLYKAcEEjcLNuJRRFNEKQXfj3PS5MUGA1wiapIdtL3fXl-9tsQ2pM6jWKlCRYxy3EqZImzSIdY6SKPmabAaxttcUlPb9K_t-S26zZqs0sa-Ue9fJhX8h1U4R7garJkv4BsOyncgN-AL1wBYbh-CuMrU3fVTI-HtuMGGI_2qLxsRpMxzvPx_gWI5cEHNsPnW6sHe_J3UDUjWbcBhPcdZXoGamVKHYun1v1uazrBdrB3eDC09mMvWqzzMplgEJ_N1cXNFz7fLuyC-dzxYq32L_3jhjPpVmAqYrO9cQvJVHsSDPYh66tXr-RHfQe21ZXUNcHr4fQ4tkDFpsac64U7WyD7zcLVhhPeV-Mk4oTDjPNoPolMaOfR2Xm7IgPjMlfj3b3yEvrhn9ErCw1rcg1a1QTHimf4PrRrbPLvnYe1QK5X0LJHJjhwPFhFc2X1Ey0OPTpr6PA9HYJZOgRTOgS1Djo6BB0dfqGbk-Prw1Pse2TguzjMGqzivIChuVZCKcoYUVIwZZylWSRKnShCpC7gryoa58y42WGHXURJJLUuiowm62ihqqtyAwU0DWUiCYxLdUpLnYFtqyjViYzTQlAxQL-nsuKegSAL3hP-AG0ZEXIw3kwFYmVCtVTDTZ4LI2yAdmYkyx9dPRWeJvBaLIT5p5LmoOOM40pUZT155gw2KSyjMMO6A6Ad6mHc_O-rbaGljt3baKF5mpQ7YE42ctdy5RXRE3jE |
link.rule.ids | 230,315,783,787,888 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduction-Mediated+Technetium-99m+Labeling+of+Monoclonal+Antibodies&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Mather%2C+Stephen+J&rft.au=Ellison%2C+David&rft.date=1990-05-01&rft.pub=Soc+Nuclear+Med&rft.issn=0161-5505&rft.eissn=1535-5667&rft.volume=31&rft.issue=5&rft.spage=692&rft_id=info%3Apmid%2F2341907&rft.externalDBID=n%2Fa&rft.externalDocID=jnm31_5_692 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon |